One study found daily aspirin reduced the risk of colon or rectal cancer recurrence, but another saw no significant survival ...

Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer.

Many Americans don't see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks ...

Aspirin could be a powerful weapon against Britain's biggest cancer killer, experts said yesterday. A U.S. study found that the painkiller can help cut the chance of developing the most common ...

Dr. Syed Hussain with Trinity Health of New England discusses the latest and trending health topics happening around the country.

Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for predicting radiotherapy benefit in DCIS, and nivolumab plus chemotherapy ...

Health guidelines now advise against the practice for most people, because it increases likelihood of brain and ...

All patients were ... Study Finds Regular Aspirin Use Associated With Greatest Reduction in Colorectal Cancer Among Those Most at Risk Aug. 1, 2024 — In a study of more than 100,000 people ...

For years, healthy older adults were advised by doctors to take a low-dose aspirin daily as a way to reduce the risk of heart ...

If you're over the age of 60, you've likely seen headlines in the last couple of years warning against previous medical advice to take aspirin as a preventative measure against heart attack and ...